Chao Zeng

588 total citations
23 papers, 466 citations indexed

About

Chao Zeng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chao Zeng has authored 23 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chao Zeng's work include RNA modifications and cancer (5 papers), Cancer, Lipids, and Metabolism (4 papers) and MicroRNA in disease regulation (4 papers). Chao Zeng is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer, Lipids, and Metabolism (4 papers) and MicroRNA in disease regulation (4 papers). Chao Zeng collaborates with scholars based in China, Japan and United States. Chao Zeng's co-authors include Min Deng, Linying Xie, Hao Liu, Min Deng, Xiaoting Jia, Zhimin He, Qinwei Qiu, Shuguang Liu, HE Xiu-sheng and Guopei Zheng and has published in prestigious journals such as ACS Nano, Small and Advanced Science.

In The Last Decade

Chao Zeng

20 papers receiving 463 citations

Peers

Chao Zeng

ONCOL

IMMUN

Chunhui Zhou China

Lanqi Gong Hong Kong

Liwei Song China

Fatma Valiyeva Puerto Rico

Jason J. Kwon United States

Guishan Jin China

Mingming Yang China

Yuquan Zhang China

Yi Ba China

Chunhui Zhou China

Chao Zeng

294 ×1.2

176 ×0.9

158 ×1.7

ONCOL

121 ×1.4

IMMUN

67 ×1.0

Citations per year, relative to Chao Zeng Chao Zeng (= 1×) peers Chunhui Zhou

Countries citing papers authored by Chao Zeng

Since Specialization

Citations

This map shows the geographic impact of Chao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Zeng more than expected).

Fields of papers citing papers by Chao Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Zeng. The network helps show where Chao Zeng may publish in the future.

Co-authorship network of co-authors of Chao Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Zeng. A scholar is included among the top collaborators of Chao Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Zeng. Chao Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Aiyun, Wenxin Zheng, Qiong Zhang, et al.. (2025). COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma. Advanced Science. 12(22). e2416360–e2416360. 5 indexed citations

Xiong, Siping, Shuguang Liu, Wei Zhang, et al.. (2025). Annotation-free genetic mutation estimation of thyroid cancer using cytological slides from multi-centers. Diagnostic Pathology. 20(1). 22–22. 1 indexed citations

Zhou, Ying‐Lin, et al.. (2024). Hypoxia-Specific Metal–Organic Frameworks Augment Cancer Immunotherapy of High-Intensity Focused Ultrasound. ACS Nano. 18(28). 18412–18424. 11 indexed citations

Zeng, Chao, Yixuan Zhang, Chao Lin, et al.. (2024). TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression. Journal of Endocrinological Investigation. 47(12). 2953–2968.

Zeng, Chao, et al.. (2024). Clinicopathological analysis of EWSR1/FUS::NFATC2 rearranged sarcoma in the left forearm: A case report. World Journal of Clinical Cases. 12(16). 2887–2893.

Fang, Lishan, et al.. (2023). Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma. Frontiers in Oncology. 12. 1060508–1060508. 2 indexed citations

Wu, Xiaobin, et al.. (2023). Pathological features of vascular wall in Dieulafoy's disease. Pathology - Research and Practice. 249. 154782–154782.

Zeng, Chao, et al.. (2022). Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto’s Thyroiditis： ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma. Frontiers in Oncology. 12. 894786–894786. 8 indexed citations

Liu, Shuguang, et al.. (2022). A Novel Defined Pyroptosis-Related Gene Signature for Predicting the Prognosis of Endometrial Cancer. Disease Markers. 2022. 1–17. 2 indexed citations

10.

Liu, Shuguang, et al.. (2022). Learn to Estimate Genetic Mutation and Microsatellite Instability with Histopathology H&E Slides in Colon Carcinoma. Cancers. 14(17). 4144–4144. 8 indexed citations

11.

Zhang, Qiwei, et al.. (2020). <p>miR-4999-5p Predicts Colorectal Cancer Survival Outcome and Reprograms Glucose Metabolism by Targeting PRKAA2</p>. OncoTargets and Therapy. Volume 13. 1199–1210. 15 indexed citations

12.

Deng, Min, Xiaodong Cai, Ling Long, et al.. (2019). CD36 promotes the epithelial–mesenchymal transition and metastasis in cervical cancer by interacting with TGF-β. Journal of Translational Medicine. 17(1). 352–352. 66 indexed citations

13.

Wang, Bin, Xiaofeng Chen, Chao Zeng, et al.. (2018). Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2. International Journal of Nanomedicine. Volume 13. 7395–7408. 71 indexed citations

14.

Deng, Min, Chao Zeng, HE Xiu-sheng, et al.. (2017). miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop. Cancer Letters. 403. 175–185. 88 indexed citations

15.

Yang, Zheng, Zhuo Wang, Zhen Li, et al.. (2017). Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer. World Journal of Surgical Oncology. 15(1). 173–173. 22 indexed citations

16.

Li, Yusheng, Wei Jiang, Yuling Hu, et al.. (2016). MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells. Oncology Letters. 12(5). 4203–4208. 47 indexed citations

17.

Wang, Wei, et al.. (2015). IL-35 Over-expression is Associated with Genesis of Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 16(7). 2845–2849. 33 indexed citations

18.

Zeng, Chao, et al.. (2014). The close correlation between heparanase and COX-2 expression in lymphangiogenesis of cervical cancer. Medical Oncology. 31(12). 314–314. 7 indexed citations

19.

Zeng, Chao, Zunfu Ke, Weiren Luo, et al.. (2013). Heparanase overexpression participates in tumor growth of cervical cancer in vitro and in vivo. Medical Oncology. 30(1). 403–403. 21 indexed citations

20.

Zeng, Chao, Yunhong Yao, Wei Jie, et al.. (2012). Up-regulation of Foxp3 participates in progression of cervical cancer. Cancer Immunology Immunotherapy. 62(3). 481–487. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact